30
1. 4. 2017.
Genome‐Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case‐Control Study
Global measures of peripheral blood DNA methylation have been associated with risk of some malignancies, including breast, bladder, and gastric cancer. Here, we examined genome‐wide measures of peripheral blood DNA methylation in prostate cancer and its non‐aggressive and aggressive disease forms.